The gold standard treatment for clinical stage T3 prostate cancer has long been the combination of radiotherapy and extended hormone therapy. However, the accuracy of clinical staging based on DRE is open to some question, since 20 percent of patients assessed to have cT3 prostate cancer today appear to be over-staged during physical examination. … READ MORE …
Filed under: Management, Treatment | Tagged: cT3 disease, Europe, surgical treatment | Leave a Comment »
Search for new and
ongoing trials on the
CTAG PCa web site
